State MD
Clinical Trials in Maryland
Recruiting clinical trials with at least one study location in Maryland. Data updated daily from ClinicalTrials.gov.
Top Conditions in Maryland
Frequently Asked Questions — Clinical Trials in Maryland
How many clinical trials are currently recruiting in Maryland?
ClinicalMetric currently tracks 384 actively recruiting clinical trials with at least one location in Maryland. The total number of registered studies—including active but not currently enrolling trials—is 384. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Maryland?
Maryland hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Prostate Cancer, Chronic Lymphocytic Leukemia, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Maryland serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Maryland?
To join a clinical trial in Maryland, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Maryland maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Maryland
NCT00246857 N/A
Recruiting
Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed...
Condition
Primary Immune Deficiency
Enrollment
5,000 pts
Location
United States, Turkey (Türkiye)
Sponsor
National Institute of Allergy
NCT05304767 Phase 3
Recruiting
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive Kar...
Condition
Schizophrenia
Enrollment
280 pts
Location
United States, Bulgaria, Czechia
Sponsor
Karuna Therapeutics, Inc., a B
NCT00001529 N/A
Recruiting
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
Condition
Graft-Versus-Host Disease
Enrollment
500 pts
Location
United States
Sponsor
National Heart, Lung, and Bloo
NCT03295981 Phase 3
Recruiting
Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of ...
Condition
Giant Cell Tumor of Bone
Enrollment
120 pts
Location
United States, Canada, India
Sponsor
St. Louis University
NCT06658730 N/A
Recruiting
Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With A...
Condition
Vascular Disease
Enrollment
1,500 pts
Location
United States, Denmark, France
Sponsor
W.L.Gore & Associates
NCT05003895 Phase 1
Recruiting
GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Maligna...
Condition
Hepatocellular Carcinoma
Enrollment
38 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT03258567 Phase 2
Recruiting
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and...
Condition
Epstein-Barr Virus Infections
Enrollment
40 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT04777357 Phase 3
Recruiting
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Carip...
Condition
Depression
Enrollment
380 pts
Location
United States, Puerto Rico, Russia
Sponsor
AbbVie
NCT05904028 Phase 3
Recruiting
Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascu...
Condition
Neovascular Age-related Macular Degeneration
Enrollment
600 pts
Location
United States, Canada
Sponsor
Jaeb Center for Health Researc
NCT07000357 Phase 3
Recruiting
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a Histo...
Condition
Cardiovascular Disease
Enrollment
15,100 pts
Location
United States, Argentina, Brazil
Sponsor
AstraZeneca
NCT06052267 Phase 3
Recruiting
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol ...
Condition
Asthma
Enrollment
2,700 pts
Location
United States, Argentina, Australia
Sponsor
Teva Branded Pharmaceutical Pr
NCT01193075 N/A
Recruiting
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT...
Condition
Charcot Marie Tooth Disease
Enrollment
5,000 pts
Location
United States, Australia, Canada
Sponsor
Michael Shy
NCT05676944 N/A
Recruiting
Vestibular Implantation in Older Adults
Condition
Other Disorders of Vestibular Function, Bilateral
Enrollment
15 pts
Location
United States
Sponsor
Johns Hopkins University
NCT06976606 N/A
Recruiting
A Study to Assess Real-world Patient Characteristics and Clinical Course for Sym...
Condition
Arrhythmogenic Cardiomyopathy
Enrollment
40 pts
Location
United States
Sponsor
Lexeo Therapeutics
NCT00001184 N/A
Recruiting
Immune Regulation in Ulcerative Colitis or Crohn s Disease
Condition
Inflammatory Bowel Disease
Enrollment
1,000 pts
Location
United States
Sponsor
National Institute of Allergy
NCT06184126 N/A
Recruiting
Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cel...
Condition
Sickle Cell Disease
Enrollment
30 pts
Location
United States
Sponsor
University of Maryland, Baltim
NCT04775485 Phase 2
Recruiting
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With R...
Condition
Low-grade Glioma
Enrollment
141 pts
Location
United States, Australia, Canada
Sponsor
Day One Biopharmaceuticals, In
NCT06581432 Phase 2
Recruiting
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanc...
Condition
Solid Tumours
Enrollment
430 pts
Location
United States, Australia, Belgium
Sponsor
Boehringer Ingelheim
NCT05327114 Phase 2, Phase 3
Recruiting
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory De...
Condition
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Enrollment
201 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
NCT07076121 Phase 2, Phase 3
Recruiting
A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine ...
Condition
Pancreatic Ductal Adenocarcinoma
Enrollment
470 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT06134232 Phase 2
Recruiting
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + ...
Condition
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Enrollment
400 pts
Location
United States
Sponsor
Dendreon
NCT05756426 N/A
Recruiting
Consortium for Optimized Integration of Bio-Artificial Blood Components for Adap...
Condition
Hemorrhage
Enrollment
250 pts
Location
United States
Sponsor
University of Maryland, Baltim
NCT04228978 N/A
Recruiting
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent...
Condition
Peripheral Artery Disease
Enrollment
212 pts
Location
United States
Sponsor
Northwestern University
NCT05533775 Phase 1, Phase 2
Recruiting
A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy i...
Condition
Mature B-Cell Non-Hodgkin Lymphoma
Enrollment
65 pts
Location
United States, Australia, Brazil
Sponsor
Hoffmann-La Roche
NCT03383575 Phase 2
Recruiting
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic...
Condition
Acute Myeloid Leukemia
Enrollment
63 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology